| Literature DB >> 17878667 |
Hideki Otsuka1, Naomi Morita, Kyo Yamashita, Hiromu Nishitani.
Abstract
FDG-PET/CT is increasingly being used for staging, restaging, and treatment monitoring for cancer patients. The introduction of a PET/CT system enables both morphological and metabolic imaging to be performed in a single session. Knowledge of the normal physiologic distribution of FDG and an understanding of the clinical indications and limitations of PET/CT enable accurate diagnosis and thus a better level of care for patients.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17878667 DOI： 10.2152/jmi.54.195
Source DB: PubMed Journal: J Med Invest ISSN： 1343-1420